2022
DOI: 10.1016/j.jbc.2022.101567
|View full text |Cite
|
Sign up to set email alerts
|

Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 27 publications
(33 reference statements)
0
6
0
Order By: Relevance
“…Accumulating evidence demonstrates that SkM is elevated during acute muscle damage and one of the SkM functions is to promote haemostasis by binding FXa and FVa thus enhancing prothrombinase activity and improving thrombin generation without the phospholipid vesicles. 47,48 Furthermore, Flood and colleagues demonstrated that SkM may indirectly escalate thrombin generation by binding VWF via the A1 domain and delivering FVIII to sites of injury. 49 Since emicizumab is not structurally like FVIII, following acute damage to skeletal muscle, it is possible a lack of clotting FVIII could prevent early haemostasis that is required to mitigate a larger muscle bleed.…”
Section: 7mentioning
confidence: 99%
See 1 more Smart Citation
“…Accumulating evidence demonstrates that SkM is elevated during acute muscle damage and one of the SkM functions is to promote haemostasis by binding FXa and FVa thus enhancing prothrombinase activity and improving thrombin generation without the phospholipid vesicles. 47,48 Furthermore, Flood and colleagues demonstrated that SkM may indirectly escalate thrombin generation by binding VWF via the A1 domain and delivering FVIII to sites of injury. 49 Since emicizumab is not structurally like FVIII, following acute damage to skeletal muscle, it is possible a lack of clotting FVIII could prevent early haemostasis that is required to mitigate a larger muscle bleed.…”
Section: 7mentioning
confidence: 99%
“…SkM is part of a family of motor proteins that seem to play a role in procoagulant activity. Accumulating evidence demonstrates that SkM is elevated during acute muscle damage and one of the SkM functions is to promote haemostasis by binding FXa and FVa thus enhancing prothrombinase activity and improving thrombin generation without the phospholipid vesicles 47,48 . Furthermore, Flood and colleagues demonstrated that SkM may indirectly escalate thrombin generation by binding VWF via the A1 domain and delivering FVIII to sites of injury 49 .…”
Section: Muscular Hematomas In Haemophilia a Patients On Emicizumabmentioning
confidence: 99%
“…This interaction enhances FXI activation by thrombin, yet not FXI activation by FXIIa. 43 Together, the polyamorous nature of the catalytic signature of FXI may be tied to the unique structure of this serine protease.…”
Section: Origin and Structurementioning
confidence: 99%
“…Recently, SkM has been reported to possess an intrinsic thrombin activation potential via FXI A3 domain binding. 14 SkM also indirectly promotes coagulation via obligatory phospholipid contamination with tissue factor. 15 Thus, SkM isoforms with potentially distinct affinities for FXI A3, or phospholipids bearing tissue factor, may indeed correlate with some of the variability observed in coagulation following trauma.…”
mentioning
confidence: 99%
“…Nonetheless, the possibility of a role of SkM in coagulation and trauma‐induced coagulopathy is intriguing. Recently, SkM has been reported to possess an intrinsic thrombin activation potential via FXI A3 domain binding 14 . SkM also indirectly promotes coagulation via obligatory phospholipid contamination with tissue factor 15 …”
mentioning
confidence: 99%